参考文献/References:
[1].Lloyd-Jones D,Adams RJ,Brown TM,et al. Heart disease and stroke statistics 2010 update: a report from the American Heart Association[J]. Circulation,2010,121(7):e46-215.
[2].黄峻.心力衰竭2019：进展和思考[J].中华心力衰竭和心肌病杂志,2020,04 (1): 52-59.
[3].中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 慢性心力衰竭基层诊疗指南(2019年)[J]. 中华全科医师杂志,2019,18(10):936-947.
[4].Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J,2016,37(27):2129-2200.
[5].Blecker S,Paul M,Taksler G,et al. Heart failure–associated hospitalizations in the United States[J]. J Am Coll Cardiol,2013,61(12):1259-1267.
[6].Ong MK,Romano PS,Edgington S,et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness After Transition–Heart Failure (BEAT-HF) randomized clinical trial[J]. JAMA Intern Med ,2016,176(3):310-318.
[7].Chen J,Normand SL,Wang Y,et al. National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries:1998-2008[J]. JAMA,2011,306(15):1669-1678.
[8].闫晶晶,田晶,王可,等. 冠心病合并慢性心力衰竭患者再住院条件脆弱模型分析[J]. 中国卫生统计,2020,37(1):66-69.
[9].Simpson J,Jhund PS,Lund LH,et al. Prognostic models derived in PARADIGM-HF and validated in ATMOSPHERE and the swedish heart failure registry to predict mortality and morbidity in chronic heart failure[J]. JAMA Cardiol,2020,5(4):432-441.
[10].Ouwerkerk W,Voors AA,Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart-failure hospitalization in patients with heart failure[J]. JACC Heart Fail,2014,2(5):429-436.
[11].Rich MW,Chyun DA,Skolnick AH,et al. Knowledge gaps in cardiovascular care of the older adult population:a scientific statement from the American Heart Association,American College of Cardiology,and American Geriatrics Society[J]. J Am Coll Cardiol,2016,67(20):2419-2440.
[12].Vidan MT,Blaya-Novakova V,Sanchez E,et al. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure[J]. Eur J Heart Fail,2016,18(7):869-875.
[13].Rodríguez-Pascual C, Paredes-Galán E, Ferrero-Martínez AI,et al. The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure:a prospective study in six Spanish hospitals[J]. Int J Cardiol,2017,236:296-303.
[14].Pellicori P,Cleland JGF,Clark AL. Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy[J]. Heart Fail Clin,2020,16(1):33-44.
[15].Haynes R,Zhu D,Judge PK,et al. Chronic kidney disease,heart failure and neprilysin inhibition[J]. Nephrol Dial Transplant,2020,35(4):558-564.
[16].Horodinschi RN,Bratu OG,Dediu GN,et al. Heart failure and chronic obstructive pulmonary disease:a review[J]. Acta Cardiol,2020,75(2):97-104.
[17].Xu S, Ye Z, Ma J,et al. The impact of chronic obstructive pulmonary disease on hospitalization and mortality in patients with heart failure[J]. Eur J Clin Invest,2021,51(1):e13402.
[18].Herrmann-Lingen,C. Chronic heart failure and depression[J] . Internist (Berl),2018,59(5):445-452.
[19].Lai CC,Sung MI,Ho CH,et al. The prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome[J]. Sci Rep,2017,7:44784.
[20].Alawieh H,Chemaly TE,Alam S,et al. Towards point-of-care heart failure diagnostic platforms:BNP and NT-proBNP biosensors[J]. Sensors (Basel),2019,19(22):5003.
[21].Chioncel O, Lainscak M, Seferovic PM,et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved,mid-range and reduced ejection fraction:an analysis of the ESC Heart Failure Long-Term Registry[J]. Eur J Heart Fail,2017,19(12):1574-1585.
[22].Liu C,Lai Y,Guan T,et al. Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure: a retrospective study[J]. ESC Heart Fail,2020,7(6): 3929-3941.
[23].Kodama K,Murata T,Dohi N,et al. Effects of pimobendan on prolonging time to rehospitalization or frequency of rehospitalization in patients with heart failure: a retrospective cohort study using a medical administrative database (PREFER Study)[J]. J Health Econ Outcomes Res,2020,7(1):71-84.
[24].Silvetti S,Belletti A,Fontana A,et al. Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials[J]. ESC Heart Fail,2017,4(4):595-604.
[25].Yancy CW,Jessup M,Bozkurt B,et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association task force on clinical practice Guidelines and the Heart Failure Society of America[J]. Circulation,2017,136(6):e137-e161.
[26].中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):760-789.
[27].Mozaffarian D,Benjamin EJ,Go AS,et al. Heart disease and stroke statistics—2016 update:a report from the American Heart Association[J]. Circulation,2016,133(4):e38-e360.
[28].Zannad F, Ferreira JP, Pocock SJ,et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction:a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials[J]. Lancet,2020,396(10254):819-829.
[29].McMurray JJV,Solomon SD,Inzucchi SE,et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med,2019,381(21): 1995-2008.
[30].Sevilla-Cazes J,Ahmad FS,Bowles KH,et al. Heart failure home management challenges and reasons for readmission:a qualitative study to understand the patients perspective[J]. J Gen Intern Med,2018,33(10):1700-1707.
[31].Celano CM,Villegas AC,Albanese AM,et al. Depression and anxiety in heart failure:a review[J]. Harv Rev Psychiatry,2018,26(4):175-184.
[32].Aggarwal M,Bozkurt B,Panjrath G,et al. Lifestyle modifications for preventing and treating heart failure[J]. J Am Coll Cardiol,2018,72(19):2391-2405.
[33].张健,张宇辉. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志,2014,42(2):98-122.
[34].Christiansen MN,K?ber L,Weeke P,et al. Age-specific trends in incidence,mortality,and comorbidities of heart failure in Denmark,1995 to 2012[J]. Circulation,2017,135(13):1214-1223.
[35].Rosamond WD, Johnson A. Trends in heart failure incidence in the community:a gathering storm[J]. Circulation,2017,135(13):1224-1226.
[36].Gheorghiade M,Shah AN,Vaduganathan M,et al. Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes:academics’,clinicians’,industry’s,regulators’,and payers’ perspectives[J]. Heart Fail Clinics ,2013,9(3):285-290.
[37].Cui X,Zhou X,Ma L,et al. A nurse-led structured education program improves self-management skills and reduces hospital readmissions in patients with chronic heart failure: a randomized and controlled trial in China[J]. Rural Remote Health,2019,19(2):5270.
[38].Sun J,Zhang ZW,Ma YX,et al. Application of self-care based on full-course individualized health education in patients with chronic heart failure and its influencing factors[J]. World J Clin Cases,2019,7(16):2165-2175.
[39].中共中央国务院印发《“健康中国2030”规划纲要》[J]. 中华人民共和国国务院公报,2016,32:5-20.
相似文献/References:
[1]戴玫,付珞,胡建英,等.慢性心力衰竭患者应用高强度间歇性有氧训练研究进展[J].心血管病学进展,2016,(3):271.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.014]
DAI Mei,FU Luo,HU Jianying,et al.Advances in Research on High-intensity Interval Training in Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2016,(8):271.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.014]
[2]张培,综述,刘剑,等.慢性心力衰竭并发肌少症的研究进展[J].心血管病学进展,2016,(3):275.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.015]
ZHANG Pei,LIU Jian.Research Progress in Chronic Heart Failure-induced Sarcopenia[J].Advances in Cardiovascular Diseases,2016,(8):275.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.015]
[3]田晶,张青,张岩波,等.慢性心力衰竭结局评价指标研究进展[J].心血管病学进展,2019,(6):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
TIAN Jing,ZHANG qing,ZHANG Yanbo,et al.Outcome Indicators for Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
[4]胡威,苏芳菊,张卫泽.左室四极导线在心脏再同步化治疗中的应用进展[J].心血管病学进展,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
HU Wei,SU Fangju,ZHANG Weize.Application of Left Ventricular Quadrupole in Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2020,(8):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
[5]郭岐龙 芦颜美 张玲 张疆华 邢强 祖克拉·吐尔洪 李耀东 周贤惠 汤宝鹏.新疆地区老年慢性心力衰竭住院患者的病因、合并症及药物治疗的多中心回顾性分析[J].心血管病学进展,2020,(4):414.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.021]
GUO Qilong,LU Yanmei,ZHANG Ling,et al.Etiology, Comorbidity and Drug Treatment of Elderly Inpatients with Chronic Heart Failure in Xinjiang: A Multi-center Retrospective Study[J].Advances in Cardiovascular Diseases,2020,(8):414.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.021]
[6]毛玉琳 何胜虎.2型糖尿病和慢性心力衰竭[J].心血管病学进展,2020,(5):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
MAO Yulin,HE Shenghu.Type 2 Diabetes Mellitus and Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(8):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
[7]郭曦滢,孙煌,樊朝美,等.非奈利酮治疗慢性心力衰竭的研究进展[J].心血管病学进展,2020,(10):1021.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.006]
GUO XiyingSUN HuangFAN ChaomeiZHANG Jian.Finerenone in the Treatment of Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(8):1021.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.006]
[8]陈晓梅 陈巧玮 曾纪娟 张庆.可穿戴设备在慢性心力衰竭患者管理中的应用进展[J].心血管病学进展,2023,(3):233.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.010]
CHEN Xiaomei,CHEN Qiaowei,ZENG Jijuan,et al.Application of Wearable Devices in Management of Patients with Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(8):233.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.010]
[9]李彤 呼海娟 崔炜.慢性心力衰竭患者脑钠肽抵抗机制的研究进展[J].心血管病学进展,2023,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.011]
LI Tong,HU Haijuan,CUI Wei.Mechanism of Brain Natriuretic Peptide Tolerance in Patients with Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(8):238.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.011]
[10]高亮 芦颜美.慢性心力衰竭并发肌少症和恶病质的诊治进展[J].心血管病学进展,2023,(7):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
GAO Liang,LU Yanmei.Diagnosis and Treatment of Chronic Heart Failure Complicated with Sarcopenia and Cachexia[J].Advances in Cardiovascular Diseases,2023,(8):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]